SS-31 is one of the more distinctive mitochondrial peptides because its research focus is close to the source of cellular energy production. Rather than being discussed only as a general antioxidant, SS-31 is studied for its interaction with cardiolipin in the inner mitochondrial membrane, where the electron transport chain operates.
That mechanism has made SS-31, also called elamipretide or Szeto-Schiller Peptide 31, relevant to research on mitochondrial dysfunction, oxidative stress pathways, cardiac energy demand, muscle fatigue and neurological ageing. The evidence base is more developed than for many research peptides, but it still needs careful wording. SS-31 is a research compound, not a proven treatment for ageing, heart disease or neurodegenerative conditions.
What is SS-31?
SS-31 is a synthetic mitochondria-targeting tetrapeptide. A tetrapeptide is a peptide made up of four amino acids. It is also known in research literature as elamipretide.
Its unusual feature is its ability to concentrate around the inner mitochondrial membrane. This membrane contains much of the machinery responsible for cellular respiration and ATP production. ATP is the main energy currency used by cells.
SS-31 is studied as a mitochondrial-targeted peptide because it binds to cardiolipin, a specialised phospholipid found mainly in the inner mitochondrial membrane. Through this interaction, researchers explore whether SS-31 can help preserve mitochondrial membrane structure, reduce lipid peroxidation and support more efficient electron transport chain function.
Why cardiolipin is central to SS-31 research
Cardiolipin helps organise the inner mitochondrial membrane. This matters because mitochondrial energy production depends on a highly structured membrane environment. If the membrane becomes damaged or disorganised, cellular respiration can become less efficient and oxidative stress may increase.
SS-31 is researched for its selective binding to cardiolipin. The proposed benefit is not simply adding another metabolic ingredient. The research idea is that protecting the mitochondrial membrane environment may improve the conditions in which ATP production takes place.
This is why SS-31 is often described as a cardiolipin protector. It is also why the compound is discussed in relation to mitochondrial membrane protection, oxidative stress reduction and cellular energy production.
SS-31 and oxidative stress pathways
Mitochondria naturally produce reactive oxygen species as part of normal metabolism. Small amounts are part of cellular signalling. Problems can arise when mitochondrial dysfunction leads to excessive reactive oxygen species production.
A damaging cycle can then develop: poorer mitochondrial function leads to higher oxidative stress, which can damage the mitochondrial membrane and make mitochondrial function worse.
SS-31 research explores whether improving the inner mitochondrial membrane environment can help reduce oxidative damage near its source. This is a more precise description than saying SS-31 simply clears free radicals. Its research value lies in the relationship between cardiolipin, membrane integrity and mitochondrial efficiency.
What improved mitochondrial efficiency may affect
Because mitochondria support energy production across many tissues, SS-31 appears in research across several areas. Experimental and clinical work has examined markers and outcomes related to:
mitochondrial membrane potential
ATP production
oxidative stress
cellular respiration
inflammatory signalling
cell survival
mitochondrial structure and function
This broad research interest does not mean SS-31 has the same level of evidence for every possible use. It means mitochondrial function is relevant to many energy-demanding systems, including skeletal muscle, the brain and the heart.
SS-31 in mitochondrial disease and fatigue research
One of the key clinical research areas for SS-31 is primary mitochondrial myopathy. In a 2018 Phase 2 trial referenced in the peptide profile data, 40 mg daily for 12 weeks in 36 patients was associated with significant improvements in the 6-minute walk test and fatigue scores, with a favourable safety profile reported in that trial.
This finding is important because it links SS-31 to measurable functional outcomes in a mitochondrial disease population. It should still be interpreted as clinical research, not as a general recommendation for use outside appropriate medical and regulatory settings.
SS-31 is also discussed in relation to exercise capacity and fatigue because mitochondrial efficiency plays a major role in energy-demanding activity. Research interest includes ATP production, recovery and oxidative stress in muscle tissue.
Why the brain is often discussed in SS-31 research
The brain has very high energy requirements. Neurons need ATP to maintain electrical gradients, communicate with other neurons and support normal cellular maintenance.
Mitochondrial dysfunction is therefore a major research topic in neurological ageing and neurodegenerative disease models. SS-31 has been studied experimentally in models involving brain ageing, cognitive decline and neurological injury.
The key limitation is evidence translation. Promising findings in mitochondrial and neurological models do not prove that SS-31 reverses Alzheimer’s disease, Parkinson’s disease or other neurodegenerative conditions in humans. Claims of that kind go beyond the current evidence.
Autophagy, cell maintenance and mitochondrial function
Autophagy is the cellular process used to identify, recycle and remove damaged components. These housekeeping systems require energy and are influenced by the wider cellular environment.
When mitochondria become severely dysfunctional, normal repair and maintenance processes may be affected. SS-31 research therefore explores whether supporting mitochondrial efficiency can create a healthier environment for these processes.
This should not be overstated. SS-31 is not accurately described as a compound that directly cleans the brain or removes toxic proteins. Its more defensible research framing is mitochondrial membrane support and energy efficiency.
SS-31, cytochrome c and cell survival pathways
Cardiolipin is involved in the relationship between mitochondria and cytochrome c, a protein that plays a role in mitochondrial energy production. Under severe cellular stress, mitochondrial membrane disruption can contribute to cytochrome c release into the cell, which may activate pathways associated with apoptosis, or programmed cell death.
Because SS-31 interacts with cardiolipin and the inner mitochondrial membrane, researchers have investigated whether it may help preserve mitochondrial integrity under stressful conditions. This is one reason the compound appears in research on ischaemia, oxidative stress and age-related mitochondrial decline.
SS-31 and heart research
The heart depends on continuous ATP production. Cardiac muscle is therefore a logical focus for mitochondrial research.
SS-31, or elamipretide, has been explored in relation to cardiac mitochondrial function, heart failure research, ischaemia-reperfusion injury and age-related cardiovascular change. In a 2019 cardioprotection study referenced in the supplied data, infusion during cardiac surgery was associated with reduced cardiac injury markers and improved mitochondrial function.
Those findings explain the interest in cardioprotective effects, but they should not be turned into claims that SS-31 is an established treatment for heart disease. Its clinical development history remains specific, regulated and more complex than many online summaries suggest.
SS-31 compared with MOTS-c, NAD+ and methylene blue
SS-31 is often mentioned alongside other mitochondrial research compounds. The overlap can be useful, but these compounds should not be treated as interchangeable.
Compound or pathwayMain research focusHow it differs from SS-31SS-31Cardiolipin binding, inner mitochondrial membrane protection, electron transport chain functionActs directly around mitochondrial membrane structure and efficiencyMOTS-cMetabolic signalling, AMPK, glucose utilisation, adaptation to metabolic stressMore focused on mitochondrial-derived signalling and metabolic regulationNAD+Electron transfer and cellular reactions linked to metabolismNAD+ precursor strategies supply metabolic inputs, while SS-31 focuses on membrane functionMethylene blueRedox chemistry and electron transport chain interactionsTheoretical overlap does not establish that combinations are safer or more effective
The distinction matters because online mitochondrial stacks often combine several experimental compounds. A plausible mechanism is not the same as controlled human evidence for a combination.
Safety considerations in SS-31 research
The supplied peptide profile describes SS-31 as having a favourable safety profile in clinical trials, with no significant side effects reported at therapeutic doses in the referenced data. Mild injection site reactions are listed as possible.
Potential stop signs in a research or clinical context include severe injection site reactions, signs of allergic reaction such as rash or breathing difficulty, unusual fatigue or weakness, cardiovascular symptoms, severe headaches or vision changes.
Known hypersensitivity to peptides is listed as a contraindication. Pregnancy and breastfeeding are also areas of limited data. These details should be interpreted cautiously and do not make SS-31 safe for everyone or suitable for self-administration.
Why sourcing matters for SS-31 in South Africa
SS-31 remains a specialised research peptide. For South African researchers comparing peptides SA listings, product identity and supplier transparency matter as much as price.
When assessing a peptide supplier SA option, look for:
a clearly identified peptide name, including SS-31 or elamipretide
stated vial strength
batch information
independent analytical testing where available
clear storage guidance, including protection from light where relevant
transparent supplier information
realistic research claims
Be cautious with listings that promise to reverse ageing, treat neurological disease or deliver guaranteed cardiac benefits. Those claims are stronger than the evidence supports.
Peptide Supermarket South Africa
Frequently asked questions
What is SS-31 used for in research?
SS-31 is studied in relation to mitochondrial function, cardiolipin protection, oxidative stress pathways, ATP production, cardiac mitochondrial function and age-related muscle or neurological models.
Is SS-31 the same as elamipretide?
Yes. SS-31 is also known as elamipretide and Szeto-Schiller Peptide 31 in research contexts.
How does SS-31 work?
SS-31 selectively binds to cardiolipin in the inner mitochondrial membrane. This is studied for its potential to reduce cardiolipin peroxidation, support electron transport chain function and improve mitochondrial efficiency.
Is SS-31 approved in South Africa as a treatment?
SS-31 is not approved by SAHPRA as a treatment for mitochondrial disease, ageing, neurological conditions or heart disease. It should be discussed as a research compound.
Does SS-31 reverse ageing?
No reliable claim can be made that SS-31 reverses ageing in humans. It has been studied in age-related mitochondrial and muscle function research, including animal work, but that is not the same as an anti-ageing treatment claim.
Where can researchers compare SS-31 prices in South Africa?
Researchers asking where to buy peptides can compare available SS-31 suppliers, vial strengths and pricing through PeptideSupermarket’s South African peptide price comparison page.
Research disclaimer: This article is for research and educational purposes only. It is not medical advice, and it does not recommend human consumption, self-administration, diagnosis or treatment.
The bottom line on SS-31
SS-31 stands out because its research begins at the inner mitochondrial membrane, one of the key structures involved in cellular energy production. Its interaction with cardiolipin has led researchers to investigate mitochondrial membrane protection, improved cellular respiration, reduced oxidative damage and better ATP production.
The most responsible summary is simple: SS-31 is being investigated as a way to support the machinery behind cellular energy production. It should not be presented as a mitochondrial cure or a proven treatment for neurodegeneration, heart disease or ageing.
To compare current South African listings, visit the PeptideSupermarket®’s peptide price comparison page and review SS-31 options by supplier, vial strength and value.
Compare SS-31 prices across the UK
Side-by-side prices from every trusted UK supplier stocking SS-31.
